Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Angelo Cascio Rizzo: Ischemic Stroke Phenotyping in ESUS – Insights from a Real-World Cohort
Sep 26, 2026, 04:58

Angelo Cascio Rizzo: Ischemic Stroke Phenotyping in ESUS – Insights from a Real-World Cohort

Angelo Cascio Rizzo, Angelo Cascio Rizzo, Vascular Neurologist at Niguarda Ca’ Granda Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of the American Heart Association, adding:

“Check out our latest paper published in the JAHA — Journal of the American Heart Association.

We assessed how the Ischemic Stroke Phenotyping System 2025 performs in 802 consecutive patients with ESUS admitted to Niguarda Hospital in Milan.

Key findings:

  • ISPS25 assigned a pathogenetic category to 313 patients (39.0%), most commonly cardioembolism.
  • The remaining 489 patients (61.0%) still classified as undetermined?
  • Second-pass diagnostic testing was performed less often in patients who remained undetermined than in those who were reassigned (46.2% vs 70.3%).
  • Additional potential embolic sources outside the ISPS25 framework were more frequent in undetermined patients (62.0% vs 42.5%). These included atrial cardiopathy, AFib first detected more than 12 months after stroke, high-risk PFO in patients aged 60 years or older, and nonstenotic carotid plaque with increased wall thickness.

ISPS25 is a useful tool for stroke classification.

To identify more potential mechanisms, we need more complete diagnostic testing and a broader assessment of potential embolic sources.”

Title: Application of the Ischemic Stroke Phenotyping System 2025 in a Real‐World Embolic Stroke of Undetermined Source Cohort: Advantages and Limitations

Authors: Angelo Cascio Rizzo, Ghil Schwarz

Angelo Cascio Rizzo: Ischemic Stroke Phenotyping in ESUS - Insights from a Real-World Cohort

Stay updated on all scientific advances with Hemostasis Today.